Fibromyalgia Treatment: Multidisciplinary Approaches for Symptom Management
Fibromyalgia is a chronic centralized pain syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, cognitive dysfunction ("fibro fog"), and somatic hypersensitivity. While no cure exists, multimodal, individualized management significantly improves function and quality of life.
Core Treatment Pillars
1. Patient Education and Self-Management
- Understanding central sensitization (amplified pain processing)
- Pacing activities (avoid boom-bust cycles)
- Setting realistic expectations and goals
2. Non-Pharmacological Therapies (First-Line per Guidelines)
- Exercise — strongest evidence: Aerobic (walking, pool, cycling) + resistance training; start low, go slow; 150 min/week target
- Cognitive Behavioral Therapy (CBT): Pain coping, catastrophizing reduction, sleep hygiene, activity pacing
- Mind-body: Mindfulness-based stress reduction (MBSR), tai chi, yoga, meditation
- Sleep optimization: CBT-I, regular schedule, stimulus control
- Physical therapy: Graded exercise, manual therapy, modalities
- Occupational therapy: Energy conservation, ergonomic adaptations, activity modification
3. Pharmacological Options (Adjunctive, Not Curative)
| Class | Agents | Evidence/Notes |
|---|---|---|
| SNRIs | Duloxetine, milnacipran | FDA-approved; pain, fatigue, function |
| Gabapentinoids | Pregabalin (FDA-approved), gabapentin | Pain, sleep; dose-titrate for side effects |
| Tricyclics | Amitriptyline (low-dose), cyclobenzaprine | Sleep, pain; anticholinergic burden in elderly |
| Muscle relaxants | Cyclobenzaprine, tizanidine | Nighttime for sleep/spasm |
| Analgesics | Acetaminophen, NSAIDs | Limited benefit for central pain; avoid opioids |
| Others | Low-dose naltrexone (off-label), medical cannabis (limited data) | Emerging; discuss risks/benefits |
